Category: Therapeutic Area
Therapeutic Area market research reports by GlobalData
-
China Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030
China Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030 Summary ... Read More
-
Australia Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030
Australia Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030 Sum ... Read More
-
United States of America (USA) Prostatectomy Procedures Count by Segments (Robotic Prostatectomy Procedures and Non-Robotic Prostatectomy Procedures) and Forecast to 2030
United States of America (USA) Prostatectomy Procedures Count by Segments (Robotic Prostatectomy Procedures and Non-Robotic Prostatectomy Procedures) and Forecast to 2030 Summary GlobalData’s “United States Prostatectomy Procedures Outlook to 2030” is a comprehensive databook report, covering key pr ... Read More
-
Mexico Prostatectomy Procedures Count by Segments (Robotic Prostatectomy Procedures and Non-Robotic Prostatectomy Procedures) and Forecast to 2030
Mexico Prostatectomy Procedures Count by Segments (Robotic Prostatectomy Procedures and Non-Robotic Prostatectomy Procedures) and Forecast to 2030 Summary GlobalData’s “Mexico Prostatectomy Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the Mexico Pro ... Read More
-
Germany Prostatectomy Procedures Count by Segments (Robotic Prostatectomy Procedures and Non-Robotic Prostatectomy Procedures) and Forecast to 2030
Germany Prostatectomy Procedures Count by Segments (Robotic Prostatectomy Procedures and Non-Robotic Prostatectomy Procedures) and Forecast to 2030 Summary GlobalData’s “Germany Prostatectomy Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the Germany ... Read More
-
Canada Prostatectomy Procedures Count by Segments (Robotic Prostatectomy Procedures and Non-Robotic Prostatectomy Procedures) and Forecast to 2030
Canada Prostatectomy Procedures Count by Segments (Robotic Prostatectomy Procedures and Non-Robotic Prostatectomy Procedures) and Forecast to 2030 Summary GlobalData’s “Canada Prostatectomy Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the Canada Pro ... Read More
-
Brazil Prostatectomy Procedures Count by Segments (Robotic Prostatectomy Procedures and Non-Robotic Prostatectomy Procedures) and Forecast to 2030
Brazil Prostatectomy Procedures Count by Segments (Robotic Prostatectomy Procedures and Non-Robotic Prostatectomy Procedures) and Forecast to 2030 Summary GlobalData’s “Brazil Prostatectomy Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the Brazil Pro ... Read More
-
BRIC Reconstruction Meshes Procedures Count by Segments (Breast Reconstruction Procedures using Meshes, Pelvic Organ Prolapse Procedures using Meshes and Urinary Incontinence Procedures using Slings) and Forecast to 2030
BRIC Reconstruction Meshes Procedures Count by Segments (Breast Reconstruction Procedures using Meshes, Pelvic Organ Prolapse Procedures using Meshes and Urinary Incontinence Procedures using Slings) and Forecast to 2030 Summary GlobalData’s “BRIC Reconstruction Meshes Procedures Outlook to 2030” is ... Read More
-
United Kingdom (UK) Prostatectomy Procedures Count by Segments (Robotic Prostatectomy Procedures and Non-Robotic Prostatectomy Procedures) and Forecast to 2030
United Kingdom (UK) Prostatectomy Procedures Count by Segments (Robotic Prostatectomy Procedures and Non-Robotic Prostatectomy Procedures) and Forecast to 2030 Summary GlobalData’s “United Kingdom Prostatectomy Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures d ... Read More
-
France Prostatectomy Procedures Count by Segments (Robotic Prostatectomy Procedures and Non-Robotic Prostatectomy Procedures) and Forecast to 2030
France Prostatectomy Procedures Count by Segments (Robotic Prostatectomy Procedures and Non-Robotic Prostatectomy Procedures) and Forecast to 2030 Summary GlobalData’s “France Prostatectomy Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the France Pro ... Read More
-
China Prostatectomy Procedures Count by Segments (Robotic Prostatectomy Procedures and Non-Robotic Prostatectomy Procedures) and Forecast to 2030
China Prostatectomy Procedures Count by Segments (Robotic Prostatectomy Procedures and Non-Robotic Prostatectomy Procedures) and Forecast to 2030 Summary GlobalData’s “China Prostatectomy Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the China Prosta ... Read More
-
Japan Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030
Japan Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030 Summary ... Read More
-
Mexico Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030
Mexico Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030 Summar ... Read More
-
Brazil Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030
Brazil Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030 Summar ... Read More
-
United Kingdom (UK) Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to trea
United Kingdom (UK) Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast t ... Read More
-
North America Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uter
North America Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030 ... Read More
-
Asia-Pacific (APAC) Reconstruction Meshes Procedures Count by Segments (Breast Reconstruction Procedures using Meshes, Pelvic Organ Prolapse Procedures using Meshes and Urinary Incontinence Procedures using Slings) and Forecast to 2030
Asia-Pacific (APAC) Reconstruction Meshes Procedures Count by Segments (Breast Reconstruction Procedures using Meshes, Pelvic Organ Prolapse Procedures using Meshes and Urinary Incontinence Procedures using Slings) and Forecast to 2030 Summary GlobalData’s “Asia-Pacific Reconstruction Meshes Procedu ... Read More
-
North America Reconstruction Meshes Procedures Count by Segments (Breast Reconstruction Procedures using Meshes, Pelvic Organ Prolapse Procedures using Meshes and Urinary Incontinence Procedures using Slings) and Forecast to 2030
North America Reconstruction Meshes Procedures Count by Segments (Breast Reconstruction Procedures using Meshes, Pelvic Organ Prolapse Procedures using Meshes and Urinary Incontinence Procedures using Slings) and Forecast to 2030 Summary GlobalData’s “North America Reconstruction Meshes Procedures O ... Read More
-
Melanoma Cell and Gene Therapy Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs and Forecast to 2031
Melanoma Cell and Gene Therapy Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs and Forecast to 2031 Summary This report includes an assessment of the disease epidemiology and 10-year patient-based forecast (PBF) across the 8MM for markete ... Read More
-
Ovarian Cancer Cell and Gene Therapy Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs and Forecast to 2031
Ovarian Cancer Cell and Gene Therapy Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs and Forecast to 2031 Summary This report includes an assessment of the disease epidemiology and 10-year patient-based forecast (PBF) across the 8MM for m ... Read More
-
Body Dysmorphic Disorder (BDD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Body Dysmorphic Disorder (BDD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in BDD therapeutics. There will be 67,698,071 total prevalent cases of BDD in 2023 in ... Read More
-
Inflammatory Bowel Disease Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Inflammatory Bowel Disease Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Inflammatory Bowel Disease - Global Clinical Trials Review, 2023 provides an overview of Inflamm ... Read More
-
Amyotrophic Lateral Sclerosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Amyotrophic Lateral Sclerosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Amyotrophic Lateral Sclerosis - Global Clinical Trials Review, 2023 provides an overview of A ... Read More
-
Cardiovascular Imaging Equipment Pipeline Report Including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update
Cardiovascular Imaging Equipment Pipeline Report Including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update Summary GlobalData's Medical Devices sector report, “Cardiovascular Imaging Equipment Pipeline Report including Stages of Development, Segm ... Read More
-
Bone Grafts and Substitutes Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures and Forecast to 2033
Bone Grafts and Substitutes Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures and Forecast to 2033 Summary Bone Grafts and Substitutes Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulato ... Read More
Research Assistance
